Evidence map›Paper›PMID 31671438›Full record

ArticleThe Journal of infectious diseases2019

Neisseria meningitidis Serogroup W Meningitis Epidemic in Togo, 2016.

Didier Mounkoro, Christelle S Nikiema, Issaka Maman, Souleymane Sakandé, Catherine H Bozio, Haoua Tall, Adodo Yao Sadji, Berthe-Marie Njanpop-Lafourcade, Agoro Sibabe, Dadja E Landoh and 7 more

Abstract readHistorical Article
In one paragraph

Article in The Journal of infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Didier MounkoroAgence de Médecine Préventive, Dapaong, Togo.
Christelle S NikiemaMinistère de la Santé et de l'Hygiène Publique, Togo.
Issaka MamanInstitut National d'Hygiène, Lomé, Togo.
Souleymane SakandéAgence de Médecine Préventive, Ouagadougou, Burkina Faso.
Catherine H BozioNational Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Haoua TallAgence de Médecine Préventive, Ouagadougou, Burkina Faso.
Adodo Yao SadjiInstitut National d'Hygiène, Lomé, Togo.
Berthe-Marie Njanpop-LafourcadeAgence de Médecine Préventive, Paris, France.
Agoro SibabeMinistère de la Santé et de l'Hygiène Publique, Togo.
Dadja E LandohOrganisation Mondiale de la Santé, Bureau Pays, Lomé, Togo.
Essofa O AbodjiAgence de Médecine Préventive, Dapaong, Togo.
Agbenoko KodjoMinistère de la Santé et de l'Hygiène Publique, Togo.
Tsidi A TamekloeMinistère de la Santé et de l'Hygiène Publique, Togo.
Téné Alima EssohAgence de Médecine Préventive, Abidjan, Côte d'Ivoire.
Détèma W MabaMinistère de la Santé et de l'Hygiène Publique, Togo.
Bradford D GessnerAgence de Médecine Préventive, Paris, France.
Jennifer C MoïsiAgence de Médecine Préventive, Paris, France.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundDuring 2014, 4 regions in Togo within the African meningitis belt implemented vaccination campaigns with meningococcal serogroup A conjugate vaccine (MACV). From January to July 2016, Togo experienced its first major Neisseria meningitidis serogroup W (NmW) outbreak. We describe the epidemiology, response, and management of the outbreak.

methodsSuspected, probable, and confirmed cases were identified using World Health Organization case definitions. Through case-based surveillance, epidemiologic and laboratory data were collected for each case. Cerebrospinal fluid specimens were analyzed by polymerase chain reaction, culture, or latex agglutination. Vaccination campaigns were conducted in affected districts.

resultsFrom January 11 to July 5, 2016, 1995 suspected meningitis cases were reported, with 128 deaths. Among them, 479 (24.0%) were confirmed by laboratory testing, and 94 (4.7%) and 1422 (71.3%) remained as probable and suspected cases, respectively. Seven epidemic districts had cumulative attack rates greater than 100 per 100 000 population. Of the confirmed cases, 91.5% were NmW; 39 of 40 available NmW isolates were sequence type-11/clonal complex-11.

conclusionsThis outbreak demonstrates that, although high coverage with MACV has reduced serogroup A outbreaks, large meningococcal meningitis outbreaks due to other serogroups may continue to occur; effective multivalent meningococcal conjugate vaccines could improve meningococcal disease prevention within meningitis belt populations.

Indexed as

Disease OutbreaksGeographyHistory, 21st CenturyHumansIncidenceMass VaccinationMeningitis, MeningococcalMeningococcal VaccinesNeisseria meningitidisPopulation SurveillanceSerogroupTogoMeningococcal VaccinesepidemicNeisseria meningitidisTogovaccination

Identifiers

PMID31671438
PMCPMC6822970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.